Moreover, recent studies showed that IGF-1 replacement or gene transfer therapy induced cytoprotective and anti-inflammatory effects leading to improvement of hepatic fibrosis in cirrhotic rats [26], [27], and IGF-1 treatment improved serum albumin levels in patients with cirrhosis [28]. The gene discussed is ALB; the disease is Cirrhosis.